Molecular Biology Of Mast Cell Growth And Differentiation
肥大细胞生长和分化的分子生物学
基本信息
- 批准号:7732464
- 负责人:
- 金额:$ 84.8万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:AllergicAnimal ModelBacteriaBehaviorBone MarrowBone Marrow CellsC-KIT GeneCalciumCarboxypeptidaseCell LineCellsCharacteristicsChymaseClinical SensitivityColumn ChromatographyComparative StudyConditionCytoplasmic GranulesDataDevelopmentDifferentiation and GrowthDiseaseEndopeptidasesEndotoxinsEnvironmentEvaluationExposure toGastrointestinal tract structureGoalsGrowthGrowth and Development functionHumanHypersensitivity skin testingIL8 geneImmune responseIn VitroIndividualInflammationInflammatoryInterleukin-1Interleukin-12Interleukin-6Knockout MiceLeadLeukotriene C4LungMediator of activation proteinMessenger RNAMolecular BiologyMusNumbersPeptide HydrolasesPeptidoglycanPertussis ToxinPlayProductionProstaglandin D2ReactionReagentRecombinantsRoleShrimpSiteStem cellsSurfaceTLR4 geneTissuesToll-Like Receptor 1TropomyosinTryptasecell growthcytokinefood allergenin vivoinhibitor/antagonistmast cellmast cell protease 4mucosal sitepreventresearch studysize
项目摘要
Human mast cells originate from pluripotential progenitor cells and migrate as immature cells from the bone marrow to tissue sites including the lung and gastrointestinal tract. There these precursors mature and participate in both innate and acquired immune responses with production of cytokines and other inflammatory mediators. Mast cell growth and development thus may occur in a tissue that interfaces with the external environment, potentially exposing mast cells during their development to bacterial products which could have an impact on their subsequent behavior. Consistent with this idea is the observation that mast cells are known to express Toll-like receptors (TLR) 1-7, and 9 both in vitro and in vivo; and exposure to such bacterial products as endotoxin or peptidoglycan leads to expression and release of cytokines. However, and in a related question, we explored whether bacteria-derived products alter the growth and development of HuMC.
We thus performed long and short-term cultures to which we added LPS or PGN. We followed specific mast cell characteristics including growth; surface FcepsilonRI and CD117 expression; degranulation, LTC4 and PGD2 release; protease expression and composition, and cytokine release.
Over 6 wks of culture, LPS had minimal effect on HuMC numbers but increased CD117, tryptase and chymase expression. PGN inhibited HuMC development. For mature mast cells, LPS in the presence of rhSCF (10 ng/ml) increased CD117, tryptase, chymase and carboxypeptidase expression, primarily in CD117low HuMC. LPS decreased FcepsilonRI expression and granule release; but had no effect on LTC4 and PGD2 production. PGN reduced HuMC numbers; and CD117 and tryptase expression. IL-1 and IL-6 (in addition to IL-8 and IL-12) were detected in short-term culture supernatants of LPS treated cells, and reproduced the increases in CD117, tryptase, chymase, and carboxypeptidase expression observed in the presence of LPS. Comparative studies with mouse bone marrow-derived mast cells from wild type, but not TLR4 knockout mice, showed increases in mRNA of mouse mast cell chymases MMCP-1, MMCP-2 and MMCP-4.
We thus concluded PGN inhibits human mst cell growth, while LPS exerts its primary effects on mature mast cells by altering cytokine production and protease composition, particularly at low concentrations of SCF. These data thus demonstrate the ability of bacterial products to alter human mast cell mediator production, granular content, and number which may be particularly relevant at mucosal sites where mast cells are exposed to these products.
In a question relevant to the evaluation of allergic sensitization, we are examining the ability of a component of shrimp, a major food allergen, to directly activate human mast cells. It is known that shrimp extracts, used as skin testing reagents, cannot be used at higher concentrations, as this leads to non-specific reactions; that is, these reactions occur in all individuals and thus do not correlate with clinical sensitivity. To identify the component of shrimp that directly activates mast cells, we fractionated shrimp extracts by size using column chromatography (S-300) and screened fractions for direct mast cell degranulating activity using the LAD2 human mast cell line. Active fractions were sequenced. Tropomyosin (Pen a 1) was identified as the active material. Recombinant Pen a 1 (rPen a 1) was used in degranulation experiments and did directly degranulate mast cells.
In vitro degranulation experiments were then undertaken. Pertussis toxin and inhibitors of PI3K, PLCgamma, PKC and Src did not prevent degranulation. rPen a 1 did increase cytosolic calcium concentrations by promoting liberation from intracellular stores and calcium entry. These observations appear to explain how shrimp extracts at higher concentrations lead to non-specific skin test reactivity. In vivo experiments in an animal model are underway.
人类肥大细胞来自多能祖细胞,并以未成熟的细胞从骨髓迁移到组织部位,包括肺部和胃肠道。在那里,这些前体成熟,并通过细胞因子和其他炎症介质的产生来参与先天和获得的免疫反应。因此,肥大细胞的生长和发育可能发生在与外部环境互动的组织中,可能在其发育过程中暴露于可能影响其随后行为的细菌产物中。与这个想法一致的是,已知肥大细胞在体外和体内表达肥大细胞(TLR)1-7和9个。暴露于内毒素或肽聚糖等细菌产物会导致细胞因子的表达和释放。但是,在一个相关的问题中,我们探讨了细菌衍生的产品是否改变了HUMC的生长和发展。
因此,我们进行了长期和短期培养,并添加了LPS或PGN。 我们遵循特定的肥大细胞特征,包括生长;表面fcepsilonri和CD117表达;脱粒,LTC4和PGD2释放;蛋白酶表达和组成,以及细胞因子释放。
超过6周培养,LPS对HUMC数量的影响很小,但CD117,胰蛋白酶和Chymase表达增加。 PGN抑制了HUMC的发展。对于成熟的肥大细胞,在RHSCF(10 ng/ml)存在下的LPS主要在CD117LOW HUMC中增加了CD117,胰酶,芝麻酶和羧肽酶的表达。 LPS降低了Fcepsilonri表达和颗粒释放。但对LTC4和PGD2的产生没有影响。 PGN减少了HUMC数量;和CD117和胰酶表达。在LPS处理的细胞的短期培养上清液中检测到IL-1和IL-6(除IL-8和IL-12),并在LPS存在下观察到CD117,Trantpase,Chymase和羧肽酶表达的增加。对野生型的小鼠骨髓衍生的肥大细胞的比较研究,但没有TLR4基因敲除小鼠,显示小鼠肥大细胞辣椒酶MMCP-1,MMCP-2和MMCP-4的mRNA增加。
因此,我们得出结论,PGN抑制了人类MST细胞的生长,而LPS通过改变细胞因子的产生和蛋白酶组成,尤其是在低浓度的SCF时对成熟肥大细胞产生主要影响。因此,这些数据证明了细菌产物改变人类肥大细胞介质产生,颗粒含量和数量的能力,这些能力可能在肥大细胞暴露于这些产物的粘膜位点特别相关。
在与评估过敏敏化有关的问题中,我们正在研究主要食品过敏原虾的能力,直接激活人类肥大细胞。众所周知,用作皮肤测试试剂的虾提取物不能以较高的浓度使用,因为这会导致非特异性反应。也就是说,这些反应发生在所有个体中,因此与临床敏感性无关。为了鉴定直接激活肥大细胞的虾的成分,我们使用柱色谱法(S-300)将虾提取物分解为尺寸,并使用LAD2 Human Mast细胞系进行了筛选的直接肥大细胞脱粒活性的筛分。测序有源分数。 tropomyosin(笔A 1)被确定为活性材料。 重组笔A 1(RPEN A 1)用于脱粒实验中,并直接脱脂肥大细胞。
然后进行体外脱粒实验。 PI3K,PLCGAMMA,PKC和SRC的百日咳毒素和抑制剂并不能阻止脱粒。 RPEN A 1确实通过促进细胞内存储和钙进入的释放来增加胞质钙浓度。 这些观察结果似乎解释了虾提取物的浓度较高如何导致非特异性皮肤测试反应性。 动物模型中的体内实验正在进行中。
项目成果
期刊论文数量(23)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Mast cells express connexins on their cytoplasmic membrane.
肥大细胞在其细胞质膜上表达连接蛋白。
- DOI:10.1016/s0091-6749(99)70239-3
- 发表时间:1999
- 期刊:
- 影响因子:0
- 作者:Vliagoftis,H;Hutson,AM;Mahmudi-Azer,S;Kim,H;Rumsaeng,V;Oh,CK;Moqbel,R;Metcalfe,DD
- 通讯作者:Metcalfe,DD
Kit signal transduction.
试剂盒信号转导。
- DOI:10.1016/s0889-8588(05)70294-x
- 发表时间:2000
- 期刊:
- 影响因子:0
- 作者:Taylor,ML;Metcalfe,DD
- 通讯作者:Metcalfe,DD
Receptor-mediated modulation of murine mast cell function by alpha-melanocyte stimulating hormone.
α-黑素细胞刺激激素对小鼠肥大细胞功能的受体介导调节。
- DOI:
- 发表时间:1999
- 期刊:
- 影响因子:0
- 作者:Adachi,S;Nakano,T;Vliagoftis,H;Metcalfe,DD
- 通讯作者:Metcalfe,DD
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Dean D Metcalfe其他文献
Plasma IL-6 correlates with disease category and with hematological parameters in patients with mastocytosis
- DOI:
10.1016/s0091-6749(02)81601-3 - 发表时间:
2002-01-01 - 期刊:
- 影响因子:
- 作者:
Knut Brockow;Cem Akin;Mary M Huber;Dean D Metcalfe - 通讯作者:
Dean D Metcalfe
Comparison of FceRI and FcγRI-dependent signaling pathways in human mast cells
- DOI:
10.1016/s0091-6749(02)82259-x - 发表时间:
2002-01-01 - 期刊:
- 影响因子:
- 作者:
Christine Tkaczyk;Yoshimishi Okayama;Dean D Metcalfe;Alasdair M Gilfillan - 通讯作者:
Alasdair M Gilfillan
Direct determination of allergen specific T cell cytokine responses during immunotherapy
- DOI:
10.1016/s0091-6749(02)82225-4 - 发表时间:
2002-01-01 - 期刊:
- 影响因子:
- 作者:
L Brigida Cayosa Hunter;Varatda Plainetr;Barbara Foster;Mary M Huber;Dean D Metcalfe;Calman Prussin - 通讯作者:
Calman Prussin
Serum tryptase levels combined with flow cytometric analysis of bone marrow aspirate mast cells differentiate systemic mastocytosis from idiopathic syndromes
- DOI:
10.1016/s0091-6749(02)81675-x - 发表时间:
2002-01-01 - 期刊:
- 影响因子:
- 作者:
Cem Akin;Arnold S Kirshenbaum;Dean D Metcalfe - 通讯作者:
Dean D Metcalfe
Dean D Metcalfe的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Dean D Metcalfe', 18)}}的其他基金
REGULATION OF CYTOKINE GENE EXPRESSION IN MAST CELLS
肥大细胞中细胞因子基因表达的调节
- 批准号:
6098983 - 财政年份:
- 资助金额:
$ 84.8万 - 项目类别:
Developmental Immunotherapeutics for Allergic Diseases and Asthma
过敏性疾病和哮喘的发育免疫治疗
- 批准号:
6099081 - 财政年份:
- 资助金额:
$ 84.8万 - 项目类别:
Fc Receptors in Mast Cell Signaling and Function
肥大细胞信号传导和功能中的 Fc 受体
- 批准号:
6431716 - 财政年份:
- 资助金额:
$ 84.8万 - 项目类别:
The Pathogenesis, Diagnosis, And Treatment Of Systemic Mast Cell Disorders
系统性肥大细胞疾病的发病机制、诊断和治疗
- 批准号:
9354692 - 财政年份:
- 资助金额:
$ 84.8万 - 项目类别:
The Pathogenesis, Diagnosis, And Treatment Of Systemic Mast Cell Disorders
系统性肥大细胞疾病的发病机制、诊断和治疗
- 批准号:
10014014 - 财政年份:
- 资助金额:
$ 84.8万 - 项目类别:
The Pathogenesis, Diagnosis, And Treatment of Systemic Mast Cell Disorders
系统性肥大细胞疾病的发病机制、诊断和治疗
- 批准号:
10272016 - 财政年份:
- 资助金额:
$ 84.8万 - 项目类别:
The Pathogenesis, Diagnosis, And Treatment Of Systemic Mast Cell Disorders
系统性肥大细胞疾病的发病机制、诊断和治疗
- 批准号:
7964210 - 财政年份:
- 资助金额:
$ 84.8万 - 项目类别:
Activation of Mast Cells in Disease States: Pharmacological Modification
疾病状态下肥大细胞的激活:药理学修饰
- 批准号:
7964545 - 财政年份:
- 资助金额:
$ 84.8万 - 项目类别:
相似国自然基金
基于口腔灌注种植体周围炎动物模型探索多细菌感染后的宿主免疫反应机制
- 批准号:82201049
- 批准年份:2022
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
基于口腔灌注种植体周围炎动物模型探索多细菌感染后的宿主免疫反应机制
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
减毒肺炎链球菌呼吸道定植诱导的重度慢阻肺动物模型建立及其机制研究
- 批准号:81670037
- 批准年份:2016
- 资助金额:53.0 万元
- 项目类别:面上项目
腰椎终板Modic改变动物模型的建立及其评估
- 批准号:81672208
- 批准年份:2016
- 资助金额:52.0 万元
- 项目类别:面上项目
粘膜免疫功能障碍性肠道细菌移位小鼠疾病模型的构建
- 批准号:81471623
- 批准年份:2014
- 资助金额:140.0 万元
- 项目类别:面上项目
相似海外基金
Gut Microbial Factors in Farming Lifestyle and Allergic Sensitization
农业生活方式和过敏致敏中的肠道微生物因素
- 批准号:
10633368 - 财政年份:2023
- 资助金额:
$ 84.8万 - 项目类别:
Regulation and Function of Oral Resident Memory T Cells
口腔驻留记忆 T 细胞的调节和功能
- 批准号:
10896496 - 财政年份:2023
- 资助金额:
$ 84.8万 - 项目类别:
Role of epithelial barrier function in food-induced anaphylaxis
上皮屏障功能在食物引起的过敏反应中的作用
- 批准号:
10655689 - 财政年份:2023
- 资助金额:
$ 84.8万 - 项目类别:
Inhibition of Th2 responses by secreted components of a common farm bacterium
常见农场细菌的分泌成分对 Th2 反应的抑制
- 批准号:
10563116 - 财政年份:2022
- 资助金额:
$ 84.8万 - 项目类别:
Depleting autoantibodies for the treatment of autoimmunity
消耗自身抗体来治疗自身免疫
- 批准号:
10698700 - 财政年份:2022
- 资助金额:
$ 84.8万 - 项目类别: